- Home
- STRO vs BSL Comparison
STRO vs BSL Comparison
Compare STRO & BSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- BSL
- Stock Information
- Founded
- STRO 2003
- BSL 2010
- Country
- STRO United States
- BSL United States
- Employees
- STRO N/A
- BSL N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- BSL Trusts Except Educational Religious and Charitable
- Sector
- STRO Health Care
- BSL Finance
- Exchange
- STRO Nasdaq
- BSL Nasdaq
- Market Cap
- STRO 172.8M
- BSL 189.7M
- IPO Year
- STRO 2018
- BSL N/A
- Fundamental
- Price
- STRO $2.08
- BSL $14.46
- Analyst Decision
- STRO Strong Buy
- BSL
- Analyst Count
- STRO 7
- BSL 0
- Target Price
- STRO $12.14
- BSL N/A
- AVG Volume (30 Days)
- STRO 1.4M
- BSL 71.9K
- Earning Date
- STRO 11-13-2024
- BSL 01-01-0001
- Dividend Yield
- STRO N/A
- BSL 9.55%
- EPS Growth
- STRO N/A
- BSL N/A
- EPS
- STRO N/A
- BSL N/A
- Revenue
- STRO $160,955,000.00
- BSL N/A
- Revenue This Year
- STRO N/A
- BSL N/A
- Revenue Next Year
- STRO N/A
- BSL N/A
- P/E Ratio
- STRO N/A
- BSL N/A
- Revenue Growth
- STRO 230.90
- BSL N/A
- 52 Week Low
- STRO $2.04
- BSL $12.19
- 52 Week High
- STRO $6.13
- BSL $14.56
- Technical
- Relative Strength Index (RSI)
- STRO 28.56
- BSL 48.02
- Support Level
- STRO $2.66
- BSL $14.41
- Resistance Level
- STRO $3.01
- BSL $14.65
- Average True Range (ATR)
- STRO 0.19
- BSL 0.11
- MACD
- STRO -0.04
- BSL -0.03
- Stochastic Oscillator
- STRO 5.64
- BSL 12.74
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About BSL Blackstone
Blackstone Senior Floating Rate Term Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It also invests in second-lien loans and high yield bonds and employs financial leverage, which may increase the risk to the Fund.